201 related articles for article (PubMed ID: 28865492)
1. Pathobiology of the 129:Stat1
Mori H; Chen JQ; Cardiff RD; Pénzváltó Z; Hubbard NE; Schuetter L; Hovey RC; Trott JF; Borowsky AD
Breast Cancer Res; 2017 Sep; 19(1):102. PubMed ID: 28865492
[TBL] [Abstract][Full Text] [Related]
2. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD
Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274
[TBL] [Abstract][Full Text] [Related]
3. Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent.
Chen JQ; Mori H; Cardiff RD; Trott JF; Hovey RC; Hubbard NE; Engelberg JA; Tepper CG; Willis BJ; Khan IH; Ravindran RK; Chan SR; Schreiber RD; Borowsky AD
PLoS One; 2015; 10(6):e0129895. PubMed ID: 26075897
[TBL] [Abstract][Full Text] [Related]
4. A mouse model for luminal epithelial like ER positive subtype of human breast cancer.
Kumar MJ; Ponvijay KS; Nandhini R; Nagarajan RS; Jose J; Srinivas G; Nagarajan P; Venkatesan R; Kumar K; Singh S
BMC Cancer; 2007 Sep; 7():180. PubMed ID: 17880731
[TBL] [Abstract][Full Text] [Related]
5. Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas.
Griffith OL; Chan SR; Griffith M; Krysiak K; Skidmore ZL; Hundal J; Allen JA; Arthur CD; Runci D; Bugatti M; Miceli AP; Schmidt H; Trani L; Kanchi KL; Miller CA; Larson DE; Fulton RS; Vermi W; Wilson RK; Schreiber RD; Mardis ER
Cell Rep; 2016 Sep; 17(1):249-260. PubMed ID: 27681435
[TBL] [Abstract][Full Text] [Related]
6. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
7. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.
Wiebe JP; Zhang G; Welch I; Cadieux-Pitre HA
Breast Cancer Res; 2013 May; 15(3):R38. PubMed ID: 25927181
[TBL] [Abstract][Full Text] [Related]
8. Estradiol Promotes Breast Cancer Cell Migration via Recruitment and Activation of Neutrophils.
Vazquez Rodriguez G; Abrahamsson A; Jensen LD; Dabrosin C
Cancer Immunol Res; 2017 Mar; 5(3):234-247. PubMed ID: 28159748
[TBL] [Abstract][Full Text] [Related]
9. Tumor-induced Stromal STAT1 Accelerates Breast Cancer via Deregulating Tissue Homeostasis.
Zellmer VR; Schnepp PM; Fracci SL; Tan X; Howe EN; Zhang S
Mol Cancer Res; 2017 May; 15(5):585-597. PubMed ID: 28108623
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of immune-related markers in breast cancer by molecular phenotypes.
Choi J; Kim DH; Jung WH; Koo JS
Breast Cancer Res Treat; 2013 Jan; 137(2):417-29. PubMed ID: 23242618
[TBL] [Abstract][Full Text] [Related]
11. CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model.
Sun X; Glynn DJ; Hodson LJ; Huo C; Britt K; Thompson EW; Woolford L; Evdokiou A; Pollard JW; Robertson SA; Ingman WV
Breast Cancer Res; 2017 Jan; 19(1):4. PubMed ID: 28077158
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic regulation of host immunity against an estrogen receptor-negative human breast cancer.
Curran EM; Judy BM; Duru NA; Wang HQ; Vergara LA; Lubahn DB; Estes DM
Clin Cancer Res; 2006 Oct; 12(19):5641-7. PubMed ID: 17000652
[TBL] [Abstract][Full Text] [Related]
13. Novel ERα positive breast cancer model with estrogen independent growth in the bone microenvironment.
Capietto AH; Chan SR; Ricci B; Allen JA; Su X; Novack DV; Schreiber RD; Faccio R
Oncotarget; 2016 Aug; 7(31):49751-49764. PubMed ID: 27391074
[TBL] [Abstract][Full Text] [Related]
14. Tumor STAT1 transcription factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived suppressor cells.
Hix LM; Karavitis J; Khan MW; Shi YH; Khazaie K; Zhang M
J Biol Chem; 2013 Apr; 288(17):11676-88. PubMed ID: 23486482
[TBL] [Abstract][Full Text] [Related]
15. Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland.
Torres-Arzayus MI; Yuan J; DellaGatta JL; Lane H; Kung AL; Brown M
Cancer Res; 2006 Dec; 66(23):11381-8. PubMed ID: 17145884
[TBL] [Abstract][Full Text] [Related]
16. A novel and cost-effective
Gupta A; Gupta G; Mehta RR; Ivancic DZ; Walker RR; Patel JR; Gallegos KM; Davidson AM; Khan SA; Mehta RG; Tilghman SL
Biol Open; 2020 May; 9(5):. PubMed ID: 32366373
[TBL] [Abstract][Full Text] [Related]
17. In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors.
Tymoszuk P; Evens H; Marzola V; Wachowicz K; Wasmer MH; Datta S; Müller-Holzner E; Fiegl H; Böck G; van Rooijen N; Theurl I; Doppler W
Eur J Immunol; 2014 Aug; 44(8):2247-62. PubMed ID: 24796276
[TBL] [Abstract][Full Text] [Related]
18. LYVE-1-expressing Macrophages Modulate the Hyaluronan-containing Extracellular Matrix in the Mammary Stroma and Contribute to Mammary Tumor Growth.
Elfstrum AK; Rumahorbo AH; Reese LE; Nelson EV; McCluskey BM; Schwertfeger KL
Cancer Res Commun; 2024 May; 4(5):1380-1397. PubMed ID: 38717149
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα(+) tumorigenesis.
Chan SR; Rickert CG; Vermi W; Sheehan KC; Arthur C; Allen JA; White JM; Archambault J; Lonardi S; McDevitt TM; Bhattacharya D; Lorenzi MV; Allred DC; Schreiber RD
Cell Death Differ; 2014 Feb; 21(2):234-46. PubMed ID: 24037089
[TBL] [Abstract][Full Text] [Related]
20. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.
Wu J; Crowe DL
Oncol Rep; 2015 Jul; 34(1):455-60. PubMed ID: 25998860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
